SPECIALTY PHARMACY

Share This Page

Specialty Pharmacy

Specialty pharmacy focuses on high cost, high touch medication therapy for patients with complex disease states. Medications in specialty pharmacy range from oral to cutting edge injectable and biologic products. The disease states treated range from cancer, multiple sclerosis and rheumatoid arthritis to rare genetic conditions.  

A specialty pharmacist may work in a variety of practice settings. Some pharmacists in this practice area work in pharmacies dedicated to only products that are considered specialty medications. In this setting, pharmacists may work in a variety of areas including dispensing, medication therapy management, patient advocacy and therapy compliance. Some pharmacists work in institutional or health system settings and may be involved with the patients therapy from in-patient to ambulatory care sites. Other pharmacists work in more traditional retail settings and either focus on certain specialty disease states at their practice sites or work with an affiliated specialty pharmacy provider to dispense these complex medications.  

SPECIALTY COVERAGE
August 18, 2016
August 18, 2016
A new survey shows high support for the Precision Medicine Initiative (PMI) Cohort Program, a landmark longitudinal research effort that aims to...
A new survey shows high support for the Precision Medicine Initiative (PMI) Cohort Program, a landmark longitudinal research effort that aims to engage at least 1 million Americans to improve the ability to prevent and treat disease based on individual differences in lifestyle.
MORE
August 18, 2016
August 18, 2016
A King County Superior Court judge has ordered the agency that oversees health insurance for Washington state's public employees to pay for...
A King County Superior Court judge has ordered the agency that oversees health insurance for Washington state's public employees to pay for expensive drugs to treat hepatitis C virus (HCV) infection in all patients, not just those with the most severe illness.
MORE
August 04, 2016
August 04, 2016
Biosimilar versions of tumor necrosis factor-a (TNF-a) inhibitors may be a viable substitution for the biologic drugs they mimic, researchers have...
Biosimilar versions of tumor necrosis factor-a (TNF-a) inhibitors may be a viable substitution for the biologic drugs they mimic, researchers have determined.
MORE